
Clean Science (CLEAN) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
2.4B
Gross Profit
1.6B
65.47%
Operating Income
811.9M
33.43%
Net Income
700.6M
28.85%
EPS (Diluted)
₹6.59
Balance Sheet Metrics
Total Assets
16.1B
Total Liabilities
1.9B
Shareholders Equity
14.2B
Debt to Equity
0.14
Cash Flow Metrics
Revenue & Profitability Trend
Clean Science Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 9.7B | 7.8B | 9.3B | 6.8B | 5.1B |
Cost of Goods Sold | 3.5B | 2.8B | 3.3B | 2.3B | 1.2B |
Gross Profit | 6.2B | 5.0B | 6.0B | 4.5B | 3.8B |
Gross Margin % | 63.7% | 64.1% | 64.6% | 66.7% | 75.5% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 176.5M | 264.4M | 180.4M | 163.5M |
Other Operating Expenses | 1.7B | 958.0M | 1.2B | 949.4M | 586.0M |
Total Operating Expenses | 1.7B | 1.1B | 1.4B | 1.1B | 749.5M |
Operating Income | 3.2B | 2.9B | 3.7B | 2.8B | 2.4B |
Operating Margin % | 33.0% | 36.7% | 39.6% | 40.6% | 47.8% |
Non-Operating Items | |||||
Interest Income | - | 28.8M | 60.3M | 60.9M | 29.4M |
Interest Expense | 4.2M | 9.3M | 2.0M | 1.5M | 910.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 3.6B | 3.3B | 4.0B | 3.0B | 2.7B |
Income Tax | 923.3M | 824.7M | 1.0B | 763.0M | 689.2M |
Effective Tax Rate % | 25.9% | 25.3% | 25.4% | 25.0% | 25.8% |
Net Income | 2.6B | 2.4B | 3.0B | 2.3B | 2.0B |
Net Margin % | 27.4% | 31.3% | 31.9% | 33.7% | 39.1% |
Key Metrics | |||||
EBITDA | 4.3B | 3.5B | 4.2B | 3.2B | 2.8B |
EPS (Basic) | ₹24.88 | ₹22.97 | ₹27.79 | ₹21.51 | ₹18.68 |
EPS (Diluted) | ₹24.88 | ₹22.96 | ₹27.78 | ₹21.51 | ₹18.68 |
Basic Shares Outstanding | 106272106 | 106245818 | 106231006 | 106218960 | 106218960 |
Diluted Shares Outstanding | 106272106 | 106245818 | 106231006 | 106218960 | 106218960 |
Income Statement Trend
Clean Science Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 200.3M | 104.4M | 124.7M | 579.0M | 93.4M |
Short-term Investments | 3.4B | 3.0B | 3.3B | 2.4B | 2.4B |
Accounts Receivable | 2.0B | 1.6B | 1.5B | 1.5B | 742.2M |
Inventory | 1.5B | 1.2B | 1.1B | 881.3M | 529.0M |
Other Current Assets | 811.8M | 1.1M | 1.9M | 2.7M | 7.9M |
Total Current Assets | 8.0B | 6.6B | 6.3B | 5.7B | 4.0B |
Non-Current Assets | |||||
Property, Plant & Equipment | 7.1B | 6.4B | 4.6B | 3.0B | 0 |
Goodwill | 32.6M | 7.4M | 6.0M | 4.7M | 2.7M |
Intangible Assets | 32.6M | 7.4M | 6.0M | 4.7M | 2.7M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 155.2M | 10.0K | 124.9M | 105.7M | -430.0K |
Total Non-Current Assets | 8.1B | 7.4B | 5.2B | 3.5B | 2.6B |
Total Assets | 16.1B | 14.0B | 11.5B | 9.2B | 6.6B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 989.0M | 1.1B | 805.1M | 1.0B | 609.9M |
Short-term Debt | 1.6M | 1.6M | 2.0M | 670.0K | 0 |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 31.4M | 22.7M | 80.7M | 1.0M | -30.0K |
Total Current Liabilities | 1.6B | 1.6B | 1.2B | 1.3B | 1.0B |
Non-Current Liabilities | |||||
Long-term Debt | 19.6M | 18.7M | 18.6M | 2.6M | 3.3M |
Deferred Tax Liabilities | 338.2M | 299.4M | 234.2M | 209.2M | 175.7M |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 357.8M | 331.1M | 263.2M | 213.2M | 182.7M |
Total Liabilities | 1.9B | 1.9B | 1.4B | 1.6B | 1.2B |
Equity | |||||
Common Stock | 106.3M | 106.2M | 106.2M | 106.2M | 106.2M |
Retained Earnings | - | 11.8B | 9.9B | 7.5B | 5.2B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 14.2B | 12.0B | 10.1B | 7.7B | 5.4B |
Key Metrics | |||||
Total Debt | 21.3M | 20.3M | 20.6M | 3.3M | 3.3M |
Working Capital | 6.4B | 5.0B | 5.1B | 4.4B | 2.9B |
Balance Sheet Composition
Clean Science Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 3.6B | 3.3B | 4.0B | 3.0B | 2.7B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 9.7M | 14.8M | 10.9M | 4.8M | 0 |
Working Capital Changes | -824.0M | -577.5M | -224.0M | -1.6B | -403.1M |
Operating Cash Flow | 2.7B | 2.7B | 3.7B | 1.4B | 2.2B |
Investing Activities | |||||
Capital Expenditures | -1.4B | -2.3B | -1.8B | -1.4B | -839.8M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -8.2B | -7.1B | -6.3B | -1.7B | -3.4B |
Investment Sales | 8.0B | 7.4B | 5.3B | 2.3B | 2.3B |
Investing Cash Flow | -1.5B | -1.9B | -2.8B | -815.6M | -1.9B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | 0 |
Dividends Paid | -531.3M | -531.2M | -557.7M | - | -33.2M |
Debt Issuance | - | - | - | 0 | 420.0K |
Debt Repayment | - | - | - | 0 | -24.0M |
Financing Cash Flow | -521.9M | -522.7M | -548.4M | 0 | -80.8M |
Free Cash Flow | 718.9M | 48.0M | 959.6M | -124.1M | 1.1B |
Net Change in Cash | 657.7M | 272.5M | 377.1M | 558.5M | 242.7M |
Cash Flow Trend
Clean Science Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
47.39
Forward P/E
34.10
Price to Book
8.98
Price to Sales
12.91
PEG Ratio
34.10
Profitability Ratios
Profit Margin
27.25%
Operating Margin
33.43%
Return on Equity
18.67%
Return on Assets
16.45%
Financial Health
Current Ratio
5.14
Debt to Equity
0.15
Beta
0.04
Per Share Data
EPS (TTM)
₹25.25
Book Value per Share
₹133.25
Revenue per Share
₹92.70
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
clean | 127.2B | 47.39 | 8.98 | 18.67% | 27.25% | 0.15 |
Asian Paints | 2.4T | 66.38 | 12.32 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.5T | 71.03 | 15.53 | 22.57% | 15.80% | 4.56 |
Atul | 195.2B | 39.05 | 3.49 | 8.55% | 8.71% | 3.56 |
Kansai Nerolac | 195.8B | 17.57 | 3.05 | 18.48% | 14.61% | 4.63 |
Vinati Organics | 181.2B | 45.18 | 6.49 | 15.42% | 18.03% | 2.24 |
Financial data is updated regularly. All figures are in the company's reporting currency.